Paediatric Oncology
Clinical research is centred on paediatric oncology, with a specific focus on Ewing sarcoma in newly diagnosed high-risk and very high-risk patients.
- Ewing sarcoma
- High-risk cancer care
- Very high-risk disease
The sponsor’s funded research is directed toward treatment strategies for children and adolescents with aggressive bone and soft tissue malignancies.
Multimodal Cancer Treatment
Its clinical activity includes multimodal treatment approaches that integrate systemic and consolidation therapies for sarcoma management.
- Consolidation therapy
- Risk-adapted treatment
- Sarcoma management
Research interest extends to therapeutic planning for patients requiring coordinated oncologic care across multiple treatment settings.
High-Dose Chemotherapy
The sponsor supports investigation of high-dose chemotherapy in the context of haematologic and oncologic toxicity assessment and treatment intensification for resistant disease.
- Treosulfan
- Melphalan
- Tolerability and safety
This area reflects interest in intensive therapeutic options for difficult-to-treat pediatric solid tumours.
Outcome-Oriented Sarcoma Research
Research efforts also address event-free survival and other clinical outcomes in high-risk sarcoma populations undergoing structured treatment pathways.
- Event-free survival
- Risk stratification
- Clinical outcome assessment
The funded trial activity is positioned within coordinated care networks across multiple research sites in Italy.
